Third Harmonic Bio Inc (THRD)
13.85
-0.38
(-2.67%)
USD |
NASDAQ |
May 17, 16:00
13.85
0.00 (0.00%)
After-Hours: 20:00
Third Harmonic Bio Shareholders Equity (Quarterly): 263.50M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 263.50M |
| December 31, 2023 | 269.08M |
| September 30, 2023 | 272.96M |
| June 30, 2023 | 278.01M |
| March 31, 2023 | 282.66M |
| Date | Value |
|---|---|
| December 31, 2022 | 289.07M |
| September 30, 2022 | 298.42M |
| June 30, 2022 | -60.56M |
| December 31, 2021 | -46.71M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-60.56M
Minimum
Jun 2022
298.42M
Maximum
Sep 2022
205.16M
Average
272.96M
Median
Sep 2023
Shareholders Equity (Quarterly) Benchmarks
| AbbVie Inc | 8.007B |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | 1.579M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 34.12M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 270.52M |
| Total Liabilities (Quarterly) | 7.02M |